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Retroviral DNA integration is catalyzed by a viral protein, the integrase (IN). IN recognizes sequences at the viral DNA
ends, specifically nicks these ends (the processing reaction), and inserts them into host DNA (the joining reaction). The
mechanism by which host DNA integration sites are selected is unknown, although it is clear that many regions are
accessible to the retroviral integration machinery. To investigate integration site selection, and to possibly influence this
process, we have used a model system in which the avian sarcoma virus (ASV) IN, and segments thereof, have been fused
to the Escherichia coli LexA repressor protein DNA binding domain (DBD). We provide evidence that a variety of such IN-
LexA DBD fusion proteins can be directed to cognate lexA operators in vitro. Binding of precise N- and C-terminal fusions
proteins to the operators is associated with a significant increase in the joining of viral DNA to sites immediately adjacent
to the lexA operator region. We also carried out domain exchange and deletion experiments which revealed that the highly
conserved ‘‘zinc-finger’’ domain of ASV IN is not essential for processing of viral DNA ends or joining of viral DNA ends to
DNA target sequences. Last, the C-terminal fusion was engineered into the viral genome and we show that this protein can
be incorporated into viral particles. Our results suggest that it might be possible to augment IN function in vivo through a
heterologous domain. These observations have implications for retroviral-mediated gene therapy. q 1996 Academic Press, Inc.
INTRODUCTION inserted into target DNA in a second reaction termed
‘‘joining’’ (Craigie et al., 1990; Katz et al., 1990). Processing
Integration of retroviral DNA into the host chromosome
and joining activities can be assayed in vitro using short
is catalyzed by a viral enzyme, the integrase (IN) (for
synthetic DNA substrates that mimic one end of retroviralreviews see Goff, 1992; Katz and Skalka, 1994; Kulkosky
DNA (Katzman et al., 1989; Craigie et al., 1990; Katz etand Skalka, 1994). IN recognizes cis-acting sequences
al., 1990.at the ends of the linear viral DNA and catalyzes their
Phylogenetic comparisons have identified two highlyinsertion into host DNA. Although many sites on the host
conserved domains that are present in retroviral and ret-DNA can be used, they are not selected entirely at ran-
rotransposon integrases (Khan et al., 1991; Kulkosky etdom (Craigie, 1992; also see Withers-Ward et al., 1994).
al., 1992 and references therein) (Fig. 1A). The conservedThe basis for integration site selection is not fully under-
N-terminal domain is characterized by a zinc finger-likestood, but it appears that DNA structure (Kitamura et al.,
motif (ZF) in the format HHCC. The function of this domain1992; Pryciak and Varmus, 1992; Muller and Varmus,
is not fully understood. ZF domain deletions (Drelich et1994; Pruss et al., 1994) or specific recruitment of the
al., 1992; Schauer and Billich, 1992; Bushman et al., 1993;preintegration complex by host components (Kalpana et
Vink et al., 1993; Buchman and Wang, 1994) or singleal., 1994; Bushman, 1995; Kirchner et al., 1995) can play
amino acid substitutions (van Gent et al., 1992; Leavitta role. Importantly, several studies have indicated that
et al., 1993; Vincent et al., 1993) have produced variablethe IN protein itself is a major determinant for integration
effects on in vitro processing and joining activities ofsite-selection (Kitamura et al., 1992; Pryciak and Varmus,
human immunodeficiency virus-1 (HIV-1) and avian sar-1992).
coma virus (ASV) integrases, ranging from mild reductionBiochemical and genetic experiments have indicated
to complete inactivation. Although the isolated domainthat integration takes place through two steps. First, IN
is not sufficient for DNA binding, several studies havenicks the viral DNA at specific sites, usually two nucleo-
suggested that it may be involved in recognition (Khantides from the 3 *-ends of each DNA strand (the ‘‘pro-
et al., 1991; Vincent et al., 1993; Hazuda et al., 1994;cessing’’ reaction) (Katzman et al., 1989). These nicking
Ellison et al., 1995) or positioning (Jonsson and Roth,sites are immediately 3 * of highly conserved CA dinucle-
1993) of viral DNA. Single amino acid substitutions of theotides. The new 3 *-OH ends of each strand are then
conserved ZF residues in HIV-1 IN produce a replication
defect in vivo (Cannon et al., 1994; Engelman et al., 1995),1 To whom correspondence and reprint requests should be ad-
dressed. Fax: (215) 728-2778. E-mail: r katz@retro2.fccc.edu. as is expected from the high degree of conservation.
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The IN catalytic domain (residues ca. 50 to 200 for ASV in vitro and can be incorporated into viral particles. Our
results suggest that there is a potential for influencingIN) is characterized by a constellation of acidic residues,
denoted the D,D(35)E motif (Kulkosky et al., 1992). This or enhancing retroviral integration in vivo using an IN
fusion protein.motif is conserved in certain bacterial transposons as
well as retrotransposons and is believed to comprise the
active site. The recently solved crystal structure of the MATERIALS AND METHODS
IN catalytic domain supports the proposed role of the
Expression and purification of LexA DBD–IN
conserved carboxylate residues (Dyda et al., 1994; Bujacz
fusion proteins
et al., 1995). The processing and joining reactions are
thought to be catalyzed by this single active site due to We constructed a set of six LexA DBD–ASV IN fusions
in which the LexA DBD replaced various portions of thethe chemical similarity of the two reactions and the gen-
eral inability to separate the two activities by mutagene- N-terminus of IN or was fused directly to either the N-
or C-termini (Fig. 1A). The LexA DBD coding region wassis (Engelman and Craigie, 1992; Kulkosky et al., 1992;
van Gent et al., 1992). The isolated catalytic domain has derived from the plasmid pRB451 (Brent and Ptashne,
1985), kindly provided by R. Brent. PCR primers werebeen shown to retain some activities: ‘‘disintegration’’
(Chow et al., 1992; Bushman et al., 1993; Vink et al., designed to amplify the DNA coding region correspond-
ing to the LexA repressor DBD, codons 1–87 of the LexA1993), or ‘‘cleavage-ligation’’ (Kulkosky et al., 1995), and
nonspecific DNA nicking in the case of ASV IN (Kulkosky repressor protein. For N-LIN, EcoRI sites were engi-
neered into both PCR primers such that the LexA DBDet al., 1995). The structure of the HIV-1 (Dyda et al., 1994)
and ASV IN (Bujacz et al., 1995) catalytic domains has coding region could be inserted into the unique EcoRI
site located at the 5*-end of the ASV IN reading framealso revealed an interface for multimerization. IN
multimers likely play a role in coordinating the insertion in the expression vector pRC23IN (formerly denoted
pRC23p32) (Terry et al., 1988). Construction of the N-of two viral ends at the host DNA insertion site in vivo.
The IN C-terminal domain is not highly conserved, but terminal deletions present in IN 39-286 and IN 52-286
has been described elsewhere (Kulkosky et al., 1995). Incontains a nonspecific DNA binding activity (Khan et al.,
1991; Mumm and Grandgenett, 1991; Vink et al., 1993; these deletion constructs, the EcoRI site at the 5*-end of
IN has been retained along with codons for the first fourWoerner and Marcus-Sekura, 1993; Engelman et al.,
1994; Lutzke et al., 1994). The C-terminal domain is es- IN amino acids. The LexA DBD coding region, adapted
with EcoRI sites, was inserted at the unique EcoRI sitesential for processing and joining activities but the pre-
cise role of this domain in recognition of viral and target in these two constructs, producing the constructs LIN
39-286 and LIN 52-286. A similar approach was used toDNAs is unknown.
Using the current knowledge of IN structure–function, construct LIN 39-207 from IN 39-207, the latter of which
was described elsewhere (Kulkosky et al., 1995). LIN 18-we have investigated whether IN activity can be influ-
enced or enhanced by fusion to a heterologous DNA 286 was constructed as follows. The 3 *-end of the LexA
DBD coding region is defined by an XmnI site. The PstIbinding domain (DBD). In theory, retroviral integration
could be directed to a chromosomal target sequence site in ampr gene is common to pRC23IN and pRB451
and was used to transfer a small PstI/XmnI cassettethat is specified by the heterologous DBD. This would
require that the chimeric IN protein is functional in vivo containing the Tac promoter derived from pRB451 along
with the coding region for the LexA DBD. This requiredand that the activity of the heterologous DBD is dominant
over the intrinsic DNA binding activity that recognizes a partial digestion of pRB451 with XmnI. The PstI/XmnI
fragment was cloned in pRC23IN that had been cleavedhost DNA. Enhanced or targeted integration may be use-
ful to optimize retroviral-mediated gene delivery or for with BssHII, repaired, and then cleaved with PstI. The
BssHII site corresponds to codon 17 of IN. Ligation ofgene knockouts (Bushman, 1995).
As a model system, we have chosen the E. coli LexA the blunt XmnI site to the repaired BssHII site resulted
in an in-frame fusion between the LexA DBD codon 87repressor DBD as a fusion partner with ASV IN. Chimeric
proteins containing the LexA DBD precisely fused at the and ASV IN codon 18. An analogous deletion missing IN
codons 5–17 (IN 18-286), was constructed by cleavingN- or C-termini, retained wild-type IN activity in vitro,
were able to bind to lexA operators, and also promoted pRC23IN with BssHII and EcoRI and inserting a small
EcoRI/BssHII linker that reestablished the first four co-the enhanced use of integration sites adjacent to the
lexA operators. While our work was in progress, one dons of IN.
The C-LIN clone (Fig. 1A) was constructed in a mannerreport (Bushman, 1994) has shown that tethering of HIV-
1 IN to DNA through an N-terminal heterologous DBD that was predicted to maintain essential portions of the
ASV pol and env reading frames (see Fig. 6). First, thecan facilitate targeted integration in vitro. However, a key
step in exploiting these observations is to express IN LexA DBD coding region was PCR-amplified from the
plasmid pRB451. The PCR primers included a BanII sitefusions in a biologically relevant manner. Here we show
that the ASV IN C-terminal fusion can promote targeting on the upstream side and an AflII site on the downstream
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side (shown in Fig. 6). The downstream PCR primer also conserved CA dinucleotide which subsequently is joined
to the target DNA. The 5*-end of the substrate plus strandcontained a stop codon which would terminate the LexA
DBD after amino acid residue 87. The BanII/AflII-adapted is labeled, and the product strand, which is two nucleo-
tides shorter than the substrate strand, is detected byLexA DBD fragment was inserted into pSP73ASVIS1
(Bouck et al., 1995) to produce an intermediate plasmid electrophoresis on a polyacrylamide–urea gel.
which contains coding sequences for the C-terminus of
In vitro assays for activity of LexA DBD–IN fusions:IN, the fused LexA DBD coding region, and a spacer
PCR-based assay for detection of joining of viral DNAthat separates the IN-LexA DBD coding region from the
ends to plasmid target sequencesoverlapping env gene (Fig. 6). The spacer also contains
a single nucleotide change that was selected in vivo,
In vitro joining assays contained approximately 0.2
which restored regulated splicing at the neighboring env
pmol of pBR711-2 plasmid DNA, 35 pmol of IN or IN-
splice site (Katz and Skalka, 1990). Fragments encoding
derivatives, and 1 pmol of a viral DNA substrate corre-
the engineered C-terminus were transferred from this
sponding to a processed form of the ASV DNA U3 end:
intermediate plasmid to pRC23IN for bacterial expres-
minus strand, 5*-ATTGCATAAGACTACA-3 *; plus strand,
sion or to the infectious viral DNA clone, pLD6, for in
5*-AATGTAGTCTTATGCAAT-3 *. IN or IN derivatives
vivo expression.
were incubated on ice together with linearized plasmid
The proteins diagrammed in Fig. 1A were purified from
DNA target for 20 min after which the viral DNA substrate
Escherichia coli as described previously (Jones et al.,
and metal (5 mM MgCl2 f.c.) were added. Reactions (201992), except for LIN 18-286 which was purified by an
ml) were carried out for 60 to 90 min at 377. The reaction
earlier method (Terry et al., 1988). All proteins were solu-
was then treated with proteinase K (200 mg/ml f.c.) and
ble and behaved similarly to the wild-type ASV IN during
0.5% SDS for 1 hr at 377C. Carrier tRNA was added and
purification. Purified LexA repressor protein was kindly
nucleic acids were purified by phenol extraction and con-
provided by E. Golemis.
centrated by ethanol precipitation. The nucleic acids
were then resuspended in 100 ml of 20 mM Tris–Cl, pHTarget sequences containing the lexA operator
7.0, 1 mM EDTA. Samples (5 to 10 ml) were removed
for analysis. Joining of the viral substrate DNA to theFor the double-strand break assay shown in Fig. 5,
the plasmid pBRBSLexAOP was used. This plasmid was heterologous target DNA was measured using a PCR-
based assay similar to that described previously (Kita-constructed by transferring a ca. 800-bp lexA operator-
containing BamHI/SalI fragment from the plasmid 1107 mura et al., 1992; Pryciak and Varmus, 1992). A ‘‘target’’
PCR primer (5*-TCTCGGAGCACTGTCCGACCG-3 *) was(kindly provided by R. Brent) to pBR322. When a partial
digest was carried out to confirm the presence of the designed which corresponded to a region ca. 100 bp 5*
of the pBR322 BamHI site in which the lexA operator24-bp operator segment, we noted a ladder of bands
consistent with the presence of several tandem opera- segment was cloned. The ‘‘viral’’ PCR primer was 17 nt
in length and was identical to the minus strand of thetors and this was confirmed by sequence analysis. A
second lexA operator substrate plasmid, pBR711-2, was viral DNA substrate, except for one additional nucleotide
(T) at the 5*-end (an irrelevant feature). The length of theconstructed. A synthetic oligodeoxynucleotide duplex
was prepared containing two tandem consensus opera- PCR product generated with these two primers corre-
sponds to the distance from the target primer site to thetors (Oertel-Buchheit et al., 1992) and a spacer sequence
(Wertman and Mount, 1985) (Fig. 1B). BamHI and SalI joining site plus the length of the viral PCR primer (17
nt). PCR conditions were: 1* at 947, 1* at 377, and 2* atrestriction sites were included for cloning into pBR322.
The operator segment from pBR711-2, shown in Fig. 1B, 727, 30–35 cycles. The target PCR primer was 32P end-
labeled and viral PCR primer was unlabeled. Productswas confirmed by nucleotide sequence analysis.
were analyzed on 7% acrylamide–urea sequencing gels.
In vitro assays for activity of LexA DBD–IN fusions: Fragment sizes were determined using a fX174 HaeIII
Processing of viral DNA ends DNA digest and a 10-bp DNA ladder (Bethesda Research
Labs) as markers.
LexA DBD–ASV IN fusions were assayed for their abil-
ity to process viral DNA ends using a model DNA sub- Plasmid double-strand break assay
strate (Katzman et al., 1989). Briefly, the substrate con-
sists of a synthetic 18-bp duplex analogous to the U3 The assays for double-strand breaks were carried out
as previously described (Terry et al., 1988), with someend of linear ASV DNA: minus strand, 5*-ATTGCATAA-
GACTACATT-3 *; plus strand, 5*-AATGTAGTCTTATGC- modifications. The reaction mix contained 20 mM Tris–
HCl, pH 7.4, 3 mM MnCl2 , 100 ng of supercoiled plasmidAAT-3 *. Incubation with IN in the presence of 3 mM
MnCl2 results in specific nicking two nucleotides from DNA or linear DNA, and 5 pmol of ASV IN or IN-derivative.
Reactions were incubated for 0.5–2 hr, heated at 687 forthe 3 *-end of the plus strand (Fig. 2A). This reaction
produces a recessed 3 *-end terminated by the highly 10 min, and then loaded on a 1% agarose gel. We ob-
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served that deproteinization did not affect the results, so strates that represent the viral DNA ends (Fig. 2; Katzman
et al., 1989). Full-length ASV IN nicks the substrate DNAthis step was not included. The gels were stained with
ethidium bromide and visualized with UV light. primarily following the conserved CA dinucleotide, as
indicated (processing activity) (Fig. 2A). Fusion of the
Transfections, virus replication assays, and Western LexA DBD to IN amino acid positions 18 or 39 (LIN 18-
blot analysis 286, LIN 39-286) resulted in retention of full processing
activity (Fig. 2A). Joining activity (Craigie et al., 1990; KatzTransfections of chicken embryo fibroblast cells were
et al., 1990), manifested by insertion of the newly formedcarried out as previously described using the DEAE-dex-
ends into other DNA substrate molecules, could also betran method (Katz and Skalka, 1990). Virus production
detected on longer exposures of the gel, and this activitywas monitored using a standard RT assay (Katz and
was similar to the nonfused, full-length IN (data notSkalka, 1990). For protein analysis, virus particles were
shown). Precise fusion of the LexA DBD to either the N-pelleted from 10 ml of culture supernatant and proteins
or C-termini of IN (N-LIN and C-LIN, respectively) alsowere fractionated on SDS –polyacrylamide gels. Western
did not affect processing and joining activities (data notblot analyses were performed using rabbit polyclonal an-
shown). Furthermore, full IN activity was observed withtibodies directed against the LexA repressor protein
the fragments IN 18-286 and IN 39-286, indicating that(kindly provided by E. Golemis) and bacterially produced
processing activities of the fusion proteins, LIN 18-286ASV IN (the ‘‘p36’’ form) (kindly provided by L. Stewart
and LIN 39-286, were not dependent on the presenceand V. Vogt (Stewart and Vogt, 1991)).
of the LexA DBD (data shown for the IN 39-286 protein
only). Fusion of the LexA DBD at residue 52 (LIN 52-286),
RESULTS
however, resulted in a dramatic reduction in processing
activity (Fig. 2A). The nonfused version of LIN 52-286Construction of ASV IN –LexA repressor DBD
was apparently unstable in E. coli and thus could not befusion proteins
purified. From these results we conclude that the ZF
The LexA repressor protein is composed of a DBD domain is not essential for in vitro activity. Also, the pres-
(residues 1–87) and a dimerization domain (residues 88 – ence of the LexA DBD does not interfere with the pro-
202). The catalytic domain of ASV IN is capable of self- cessing activity of any of the proteins tested.
association (Andrake and Skalka, 1995) and we reasoned We previously observed that deletion of the C-terminus
that it might provide the dimerization function required of ASV IN (IN 1-207, Kulkosky et al., 1995) resulted in
for high affinity binding of the LexA DBD to operator loss of processing and joining activities, except for reten-
sequences (Kim and Little, 1992; and references therein). tion of a Mn2/-dependent endonuclease activity which
We also hypothesized that if either or both the ZF and cleaves between the conserved C and A (‘‘03’’ cut), as
the C-terminal domains of ASV IN are involved in target well as other sites. The IN 39-207 catalytic domain frag-
DNA recognition, then replacement of these domains ment also retains ‘‘03’’ nicking activity (Kulkosky et al.,
with a heterologous DNA binding domain could result in 1995; Fig. 2B) and fusion of the LexA DBD (LIN 39-207)
functional complementation. We designed several trun- had little effect on this activity (Fig. 2B).
cated and full-length ASV IN fusion proteins containing
the LexA repressor DBD (Fig. 1A). The LexA DBD was
The LexA DBD can influence IN joining site selectionfused to the N-terminus at residues 18, 39, and 52, which
resulted in partial or complete removal of the ZF domain. Having demonstrated that many of the fusion proteins
In addition, we designed several analogous IN deletion were active, we asked whether fusion of the LexA DBD
mutations. Replacement of a portion of the IN C-terminal to ASV IN could influence joining site selection. IN or IN
domain with the LexA DBD produced an unstable protein fusion proteins were incubated with linearized plasmid
which could not be analyzed further (data not shown). DNA which contained two tandem lexA operators (see
The LexA DBD which retains endonuclease activity as Fig. 1B). Short DNA duplex substrates that represent the
well as a cleavage-ligation activity (Kulkosky et al., 1995) processed viral DNA ends were then added. We used a
was also fused to the catalytic domain to produce LIN PCR-based assay to detect joining of the viral DNA sub-
39-207. Finally, we constructed two fusions in which the strate strands to the plasmid target (Kitamura et al., 1992;
LexA DBD was present at either the N- or C-terminus of Pryciak and Varmus, 1992). The size of the resultant PCR
full-length IN (N-LIN and C-LIN, respectively). fragments reflects the distance from a fixed site on the
plasmid to the joining site. The fixed primer was selectedProcessing and endonuclease activities of IN–LexA
to measure joining events in the vicinity of the lexA opera-DBD fusion proteins
tors. It should be noted that this assay detects joining of
what is equivalent to only a single viral DNA end.Equivalent molar amounts of the fusion proteins and
deletion mutants shown in Fig. 1A were assayed for in As expected, nonfused IN (Fig. 3, lane 1) catalyzes
joining of the viral DNA substrate to many sites on thevitro processing activity using short DNA duplex sub-
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FIG. 1. (A) Schematic representation of LexA repressor DBD-ASV IN fusion proteins. ASV IN and segments are indicated as open boxes; LexA
DBD is indicated as filled boxes. Top, full-length ASV IN (286 residues) is shown; the positions of the relevant highly conserved residues are
indicated using the single letter code. The carboxylate residues characteristic of the catalytic domain are shown in bold (the D,D(35)E motif). The
dashed vertical lines indicate the first four amino acids of IN, which are retained as a leader or spacer in many of the constructs. Hatched area
in LIN 39-207 indicates two heterologous amino acids (Kulkosky et al., 1995). (B) LexA operator region present in pBR711-2. Flanking restriction
sites in pBR322 are indicated. Dashed vertical lines indicate axis of dyad symmetry for each operator and boxed region indicates spacer between
operators.
target plasmid. As indicated by the varying intensities of centered around a region ca. 23 base pairs 5* of the axis
of dyad symmetry of operator 1 (Fig. 1B), as estimatedbands, the joining sites are not used with equal efficien-
cies. This observation is consistent with earlier studies using a 10-base pair ladder as a marker. A second en-
hanced site was noted closer to the primer (lower arrow)which indicated that sequence-dependent variations in
DNA structure can likely influence integration site selec- and some enhancement was also noted at the border of
the operator region. As shown in lane 2, binding of thetion in vitro (Kitamura et al., 1992; Pryciak and Varmus,
1992; Muller and Varmus, 1994; Pruss et al., 1994). If complete LexA repressor protein to the operator region
does not result in enhancement at these sites when thepurified LexA repressor protein was added prior to the
addition of IN, a ‘‘footprint’’ was observed over the lexA nonfused IN is added in ‘‘trans.’’ These results suggest
that LexA DBD directs the N-LIN and C-LIN fusion pro-operator region (lane 2). We interpret this pattern to mean
that the bound repressor blocks access of IN to the oper- teins to the operator region and that the bound proteins
join viral DNA ends into specific nearby sites. However,ator region and prevents joining events from occurring
in this region, as has been described previously with other possible mechanisms of enhancement cannot be
excluded (see Discussion). We also note that preincuba-other DNA-binding proteins (Pryciak and Varmus, 1992;
Bushman, 1994; Muller and Varmus, 1994). A general tion with approximately equimolar amounts of the com-
plete LexA repressor protein did not alter the joiningreduction in joining was also noted, which may be due
to some nonspecific binding of the LexA repressor pro- patterns produced by N-LIN and C-LIN (lanes 4 and 6).
This result suggests that both of these fusion proteinstein to the plasmid DNA target.
The joining patterns produced by N-LIN and C-LIN compete well with the native repressor protein for bind-
ing to lexA operators.(lanes 3 and 5, respectively) were significantly different
from the pattern produced by nonfused IN (lane 1). A
footprint was observed over the lexA operator region and Effect of ZF deletions on IN–LexA DBD joining
thus we conclude that these fusion proteins are able to activity
bind to the lexA operators. Again, we interpret the foot-
print as a block in access to this region by other active, Since two of the N-terminal intradomain fusions, LIN
18-286 and LIN 39-286, were active for processing (Fig.unbound fusion proteins. Strikingly, as compared to wild-
type IN, the use of the same neighboring joining sites 2A), we used the PCR-based assay to measure their
ability to direct joining activity to the lexA operator region.was enhanced significantly with both N-LIN and C-LIN
(Fig. 3, upper arrow). The major enhanced sites were The results (Fig. 4) indicate that the N-terminal deletions
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FIG. 2. Processing and DNA nicking activities of ASV IN and IN derivatives. The model substrate that represents the viral DNA end is diagrammed
at the bottom of each panel (asterisk indicates 32P label). Time course is indicated; NP indicates a control incubation with no protein added. Reaction
products were fractionated on polyacrylamide–urea sequencing gels. S indicates the labeled strand from the duplex substrate. The processing
activity of ASV IN cleaves the substrate strand between the A and T (as indicated by arrow in diagram), exposing the highly conserved CA that
becomes joined to host DNA. This produces a strand that is two nucleotides shorter than the substrate (denote’’ 02’’ band). (A) Processing activity
of wild-type IN and selected LexA DBD fusion proteins, as indicated. A secondary IN activity nicks between the C and A residues (03 band). (B)
Activity of the fused and nonfused ASV IN catalytic domain. The prominent nicking site on the substrate is diagrammed below.
do not interfere with the ability of these proteins to cata- 5 and 6), the highly preferred neighboring joining site
(arrow) is not observed with LIN 18-286 (lane 7). Welyze joining of viral DNA ends to the plasmid target DNA
(compare lanes 2 through 4). We did note a slight reduc- conclude that the complete ASV IN ZF domain is not
required for joining of viral DNA substrates to plasmidtion in the overall activity, as well as subtle variations in
joining site selection, as compared to nonfused, full- DNA targets. However, the ZF deletion seems to affect
activity of the IN complex bound at the operator site (seelength IN (compare lane 2 with lanes 3 and 4). In the
case of the fusion LIN 18-286, a joining pattern identical Discussion).
LIN 39-286 shows significantly reduced activity asto IN 18-286 was produced, except that a footprint at the
operator region was observed, indicating that the former compared to the nonfused counterpart, IN 39-286 (com-
pare lanes 4 and 8). This is in contrast to the resultsprotein is bound at the operator sites (compare lanes 3
and 7). In contrast to results with N-LIN or C-LIN (lanes observed with the processing assay (Fig. 2) and suggests
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vance of this activity is unknown, it provided us with an
independent assay for measuring the selectivity of LexA
DBD–IN fusions for lexA operators. The supercoiled
DNA substrate used in Fig. 5A is a pBR322 derivative
lacking lexA operator sequences. Nonfused IN, and rep-
resentative IN fragments and fusions, were incubated
with this plasmid in the presence of MnCl2 and the prod-
ucts were analyzed by agarose gel electrophoresis (Fig.
5A). The two fusion proteins (lanes 4 and 7), two analo-
gous nonfused catalytic domain fragments (lanes 5 and
6), and wild-type IN (lane 3) all displayed similar levels
of nicking activity (as indicated by production of FII DNA)
and double-strand break activity (as indicated by produc-
tion of FIII DNA). These results verify that the DNA endo-
nuclease activity maps to the ASV IN catalytic domain.
Results from an experiment in which the supercoiled
plasmid substrate contained tandem lexA operators are
shown in Fig. 5B. With this substrate, the double-strand
break activity was much higher with the four proteins
that contain the LexA DBD (Fig. 5B lanes 3, 4, 5, and 8)
FIG. 3. PCR-based assay for detection of in vitro joining events into
plasmid DNA. The indicated proteins were incubated with the target
plasmid pBR711-2, plus (/) or minus (0) preincubation of the substrate
DNA with the LexA repressor protein. The PCR products were fraction-
ated on a 7% acrylamide–urea sequencing gel. The relevant fX174
DNA markers are indicated on the left. The position of the lexA operator
region was determined using a 10-bp ladder. Arrowheads indicate
enhanced joining sites.
that the plasmid joining assay is more stringent. As might
be expected from the results in Fig. 2, the LIN 52-286
and LIN 39-207 proteins showed no joining activity under
these conditions (lanes 9 and 10).
Targeting of IN endonuclease activity to lexA
operators FIG. 4. PCR-based assay for detection of in vitro joining events, as
described in the legend of Figure 3. Proteins used in each assay are
With Mn2/ as a cofactor, ASV IN is able to nick su- shown above each lane. A control reaction was incubated without IN
percoiled plasmid DNA’s and produce double-strand (lane 1, -IN). Symbols and markers are as described in the legend of
Figure 3.breaks (Terry et al., 1988). Although the biological rele-
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FIG. 5. Nicking and double-strand break assay for ASV IN and derivatives. Supercoiled substrate [form I (F I)] was used in A and B. Linear
substrate was used in C. Proteins used for each reaction are indicated above the lanes. (A) The plasmid pNDE-1, a pBR322 derivative lacking
lexA operators was used as a substrate. DNA forms I, II, and III are indicated. Marker DNA sizes are indicated in kb. Lane 1, marked CON, indicates
that the reaction was incubated in the absence of IN. (B) The plasmid containing lexA operators, pBRBSLexAOP, was used as a substrate. The
form II band in the starting material (CON, lane 1) may also contain supercoiled dimer plasmid. A double-strand break at only one of the two
possible sites would produce a linear dimer [denoted F III (D?)]. (C) As in B, except that a PstI-linearized version of the pBRBSLexAOP plasmid
was used as a substrate. Markers for double-strand breaks at the lexA operator region were generated by cleavage of pBRBSLexAOP with PstI
plus XhoI.
than with the corresponding nonfused catalytic domain be directed to the lexA operator sites by fusion to the
LexA DBD. In the joining experiments in Figs. 3 and 4,fragments or full-length IN (lanes 2, 6, and 7). Although
these assays are not highly quantitative, the selectivity we used Mg2/ as a cofactor in order to minimize this
activity.of the fusion proteins for the lexA operator-containing
substrate seems most pronounced when the activities
of IN 39-207 and LIN 39-207 are compared (Fig. 5B, lanes In vivo analysis of the C-LIN fusion protein
7 and 8, respectively).
A linear DNA substrate was used in Fig. 3C. This sub- One long-term goal of our work is to evaluate IN modifi-
cations that might be used to influence, direct, or en-strate addresses the contribution of DNA structure to the
activities observed in Fig. 5B and also allows mapping of hance retroviral DNA integration in vivo. Since the N-
terminus of IN is normally fused to RT in the Gag-Polthe double-strand breaks. The lexA operator-containing
substrate was linearized with PstI, purified, and then in- polyprotein precursor of retroviruses, engineering of a
DBD at this site (e.g., as in N-LIN) would require introduc-cubated with nonfused, full-length IN or LIN 18-286. The
results (Fig. 5C) show that two populations of fragments tion of a new viral protease (PR) cleavage site to release
the IN fusion from the precursor. In the case of ASV, INof ca. 3400 and 1300 bp were produced after incubation
with LIN 18-286 (lane 5). These fragments comigrated exists both as a domain of the RT b-chain, as well as a
free protein (Katz and Skalka, 1994); a heterologous DBDwith the two marker fragments generated by cleavage of
the substrate plasmid with XhoI (lane 3), which cleaves at at the N-terminus of IN would likely affect folding of the
RT b-chain. We therefore constructed an ASV DNA clonethe operator sites. These results indicate that the major
double-strand break site corresponds to the lexA opera- which encodes C-LIN. In this case the DBD is fused to
the C-terminus of the RT b-chain as well as to the C-tor region. All LexA DBD– ASV IN fusions showed similar
patterns using the linear substrate (data not shown). The terminus of IN. This approach required reconstruction of
the 3 *-end of the pol gene in a manner which would notbands produced by LIN 18-286 were broad, suggesting
that the ends might be frayed (Fig. 5C, lane 5). Fraction- disturb cis-acting RNA signals or other coding regions.
Normally, the 3 *-end of the pol gene partially overlapsation of labeled DNA’s on higher resolution gels con-
firmed that the termini produced by LIN 18-186 corre- with the env coding region (Fig. 6). The pol portion of the
overlap encodes a 37 amino acid peptide that is removedsponded to many sites within, and flanking, the lexA op-
erator region (data not shown). from the C-terminus of both the RT b-chain and IN by PR
during virion morphogenesis. This peptide is apparentlyFrom these experiments we conclude that the Mn2/-
dependent nicking activity of the IN catalytic domain can nonessential for viral replication in tissue culture (Katz
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FIG. 6. Strategy for construction of an ASV genome encoding C-LIN. Top, Diagram of the env–pol overlap region of ASV. A small peptide of 37
amino acids (stippled region) is normally removed by the viral protease (PR) from the C-terminus of IN after assembly. The env 3 *-splice site (ss)
is indicated. Middle, In pLD6IS1 (Katz and Skalka, 1990), a stop codon has been introduced that corresponds to the PR cleavage site thus creating
an untranslated spacer (ut) between the pol and env genes. Dashed box denotes the region that encoded the C-terminal peptide in the wild-type
construct. Using pLD6IS1 as an intermediate, pLD6 C-LIN was constructed by inserting a PCR-generated LexA DBD coding fragment (filled box)
between existing BanII and AflII sites. Bottom, The two PCR primers are shown, along with amino acids encoded at the IN-LexA DBD junction
(vertical dashed line) and at the new C-terminus of the C-LIN fusion. Sequences in bold indicate LexA DBD coding sequences and corresponding
amino acids.
and Skalka, 1988). Our strategy was to replace the coding parent has been shown to replicate similar to wild type
(Katz and Skalka, 1990), the defect must be due to thesequences for this peptide with the coding sequence for
the LexA DBD. Based on known specificities (Katz and additional alterations that produced pLD6 C-LIN. West-
ern blot analysis (Fig. 8) using both anti-IN and anti-LexASkalka, 1994), we anticipated that the PR cleavage site
would be destroyed by the fusion step, which places a repressor antibodies demonstrated that viruses pro-
duced from pLD6 C-LIN-transfected cultures containedlysine residue at the P1* position of the cleavage site. In
order to preserve the intronic portion of the env splice a mixture of C-LIN (ca. 42 kDa) and a nonfused IN spe-
cies (32 kDa). As predicted, the LexA DBD was alsoacceptor site (which also overlaps with IN coding) we
used as a parental clone, pLD6IS1 (Katz and Skalka, detected on the b-chain of RT (Fig. 8B). At ca. 30 days
posttransfection, the C-LIN to IN ratio was approximately1990; Bouck et al., 1995), which contains an untranslated
spacer between env and pol (Fig. 6, denoted ut). The one to five (Fig. 8A). In similar Western blots from virus
collected at earlier times (e.g., Days 16 and 17) the C-spacer includes a cis-acting suppressor mutation which
was selected in vivo to maintain RNA splicing regulation LIN to IN protein ratio was approximately one to two
(data not shown), suggesting a gradual loss of the LexA(Katz and Skalka, 1990; Bouck et al., 1995).
Susceptible chicken embryo fibroblasts were trans- DBD during multiple rounds of infection. Although the
free LexA DBD could not be readily detected in viralfected with the pLD6 C-LIN viral construct (Fig. 7A). A
significant delay in appearance of C-LIN virus was ob- particles (data not shown) we cannot rule out proteolytic
removal of this domain prior to or after virus assemblyserved as compared to wild type. Since the pLD6IS1
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al., 1992; Pryciak and Varmus, 1992; Muller and Varmus,
1994; Pruss et al., 1994; and references therein). More
recent work has implicated components of the transcrip-
tional apparatus as possible cofactors in integration-site
selection (Kalpana et al., 1994; Kirchner et al., 1995; also
see Bushman, 1995). The work presented here has exam-
ined a specific DNA target sequence as a determinant
of integration site selection. This required that IN be
augmented with a new binding domain such that it is
directed to the specified DNA sequence. This approach
allows analysis of the catalytic activity of IN molecules
bound to a particular site on the DNA and may be useful
for targeting or enhancing retroviral integration in vivo.
Our results are consistent with the binding of the N-
LIN and C-LIN fusion proteins to lexA operator se-
quences which promotes the enhanced use of adjacent
integration sites. However, we cannot entirely exclude
the possibility that the bound proteins may be distorting
the DNA in some way to promote use of this site by
unbound molecules. Two observations argue against this
interpretation. First, when the complete LexA repressor
protein is bound at the operator, nonfused IN does not
use the neighboring site preferentially. Second, the LIN
18-286 protein is active and is bound to the operator, but
does not promote use of the neighboring site (Fig. 4).
These results indicate that simple binding of either the
native repressor protein or a fusion protein is insufficient
to enhance the use of this site.
While our studies were in progress, Bushman (1994)
FIG. 7. Virus replication as measured by the reverse transcriptase showed that fusion of the lambda repressor DBD to the
assay after DNA transfection and infection of CEFs. (A) CEF cells were
N-terminus of HIV-1 IN could promote enhanced integra-transfected with the wild-type viral DNA clone, pLD6 (WT), and the C-
tion at many sites near the cognate operators. Our resultsLIN construct, pLD6 C-LIN (C-LIN). Virus production was monitored
are in general agreement with this study. However, withby the reverse transcriptase assay. Control cultures (CON) were not
transfected. (B) Supernatants collected on Day 25 from A were normal- the comparable fusion, N-LIN, we observed only one
ized for RT activity and were applied to fresh CEF cultures. Control major and several minor regions of enhancement. There
(CON) cultures were not infected.
are many possible explanations for this difference, but it
is interesting to speculate that the maintenance of the
complete interdomain hinge in the lambda repressor fu-(see Discussion). Culture supernatants were collected at
sion may allow significant protein flexibility and thisDay 25 from the transfections shown in Fig. 7A, normal-
might result in a more promiscuous use neighboringized by reverse transcriptase activity and then applied to
DNA target sites. In the N-terminal LexA fusion describedfresh cells. Virus derived from wild-type or pLD6 C-LIN
here (N-LIN), the complete LexA hinge domain was notcultures replicated at similar rates (Fig. 7B), indicating a
included, although some interdomain flexibility might begenetic change that restored full replicative capacity.
maintained (Oertel-Buchheit et al., 1993). DNA flexibilityFrom this experiment we conclude that the C-LIN protein
is likely important in selecting neighboring joining sitescan be incorporated into virus particles but the virus
(Bushman, 1994), but restricted interdomain protein flexi-encoding C-LIN is partially defective and can be geneti-
bility could favor more focused integration site selectioncally unstable (see Discussion).
by the operator-bound IN, as we have observed. Interest-
ingly, LIN 18-286 is active for joining viral DNA to plasmidDISCUSSION
DNA and is able to bind to operators as indicated by
‘‘footprinting’’; however, as mentioned above, the opera-Recent experiments using a sensitive PCR-based
assay have indicated that many regions of host cell DNA tor-bound fusion does not show preference for the neigh-
boring sites observed with N-LIN (Fig. 4). These resultsare accessible for ASV integration (Withers-Ward et al.,
1994). Several studies have also indicated that structural suggest that fusion within the ZF domain may severely
restrict interdomain flexibility such that access to thefeatures of chromatin or DNA may influence local retrovi-
ral integration site selection (Craigie, 1992; Kitamura et neighboring joining site is prohibited. Alternatively, the
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FIG. 8. Western blot analysis of virus collected at Day 30 posttransfection. The viral clone used for the original transfection is indicated above
each lane (see legend of Fig. 7). Virus particles were collected by pelleting and were applied to a 10% SDS–polyacrylamide protein gel. Western
blots were probed with (A) anti-IN or (B) anti-LexA repressor protein rabbit polyclonal antibodies. The blots were developed with 125I-labeled protein
G. Molecular weight markers in kilodaltons are indicated on the left side of each panel. Positions of nonfused and fused proteins are indicated at
the right side of each panel.
partial ZF deletion may affect the formation of an active by the footprints), we cannot exclude the possibility that
this is due to half-site binding on either or both operatorsIN complex at the operator site.
Like the N-terminal fusion, the C-LIN fusion protein (Kim and Little, 1992). However, we found that the N-
LIN and C-LIN fusions were apparently able to efficientlyalso shows a preference for the joining sites neighboring
the operator in vitro. This result indicates that there is compete for operator sites with the native LexA repressor
protein (Fig. 3). All of the IN–LexA DBD fusions we havesignificant tractability in the way the fusion protein can
be tethered to the target region and still recognize neigh- analyzed show some degree of selectivity for operator
sequences. Although we have not directly measured theboring integration sites. The fact that the same neigh-
boring site is selected with N-LIN and C-LIN also sug- relative binding of nonfused IN versus fused IN, the re-
sults in Fig. 5 indicate an approximate 5- to 10-fold selec-gests that the two fusion proteins are similarly positioned
on the DNA. One interpretation is that the N- and C- tivity for introducing double-strand breaks at or near the
operator region by the LIN fusion proteins. It seems mosttermini are adjacent in the native ASV IN structure such
that fusion with either terminus would produce a similar likely that the increase in double-strand break activity is
the result of a high local concentration of LIN moleculesarrangement on the DNA. Immunological probing has
also suggested that the N- and C-termini of HIV-1 IN are at the operator region which increases the probability of
closely spaced breaks on opposite DNA strands.adjacent (Bizub-Bender et al., 1994).
The juxtaposition of the LexA DBD and the IN dimeriza- The selectivity of the fusion proteins for directing inte-
gration to the lexA operator region is clearly limited.tion domain is likely important to promote correct align-
ment of each DBD to each half-site of the operator (Go- Greater selectivity might be achieved by inactivating the
IN domain that is normally responsible for sequence-lemis and Brent, 1992; Oertel-Buchheit et al., 1993). In our
case, we wished to minimize the heterologous domain so independent binding to host DNA, if such a discrete do-
main does indeed exist. A sequence-independent DNAthat the fusion protein might be amenable for assembly
into virus particles. We therefore fused only the LexA binding activity maps to the C-terminus of IN (Khan et
al., 1991; Mumm and Grandgenett, 1991; Vink et al., 1993;DBD to IN and expected that the IN dimerization function
would complement the LexA dimerization function and Woerner and Marcus-Sekura, 1993; Engelman et al.,
1994; Lutzke et al., 1994) and we have noted that removalthus promote high affinity binding. ASV IN functions as
a multimer (Jones et al., 1992) and biochemical mapping of this entire domain appears to allow increased selectiv-
ity in the double-strand break assay shown in Fig. 5B.studies have indicated that self-association functions are
contributed by both the catalytic domain and the C-termi- Partial replacement of the ZF domain did not result in
greater selectivity for the lexA operator. However we ob-nal domain (Andrake and Skalka, 1995). The recently
solved crystal structures of the HIV-1 (Dyda et al., 1994) served that fusion of the LexA DBD to amino acid posi-
tions 18 and 39 of ASV IN (LIN 18-286, LIN 39-286) hadand ASV (Bujacz et al., 1995) IN catalytic domains have
also identified an extensive interface. Although we ob- no major deleterious effect on processing and joining
activity. To determine if the LexA DBD might be somehowserve high occupancy of the lexA operators (as indicated
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complementing ZF domain function in vitro, we analyzed In summary, we describe active IN fusion proteins con-
taining a targeting domain. We also show that one ofthe corresponding deletion mutants (IN 18-286, IN 39-
286). We found that these mutant proteins also exhibit these fusion proteins can be incorporated into viral parti-
cles. It can be imagined that a fused domain could besignificant activity. Thus, the ZF domain is not essential
for processing or joining to a heterologous target DNA used to target the retroviral preintegration complex to
DNA, as well as chromatin components in vivo. The tar-in vitro. Similar results have been reported previously,
except that fusion of short heterologous peptides was geting or enhancement of retroviral integration may be
extremely useful for basic research, as well as for generequired to complement the ASV IN ZF deletion (Bush-
man and Wang, 1994). therapy.
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